23 September 2026

TGA pulls herbal ingredient over anaphylaxis risk

5 minute read

Andrographis will no longer qualify for Australia’s low-risk listed medicines pathway after continuing reports of severe allergic reactions and a fatal case.

This content is for AHPRA registered professionals only.
Login Join Now

End of content

No more pages to load

Register for a new account

Email Address

Password

Confirm Password

First Name

Last Name

Full Name LEAVE THIS BLANK

What field do you work in?

Type of University work:

Industry Specialty:

Other:

Billing Address

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

I agree to the Terms and conditions and privacy policy *

Processing...

TGA pulls herbal ingredient over anaphylaxis risk

DoHDA invented an AI-powered fraud detection tool. It stunk

Inhaled RNA therapy hits asthma target

Spring asthma warning as pollen season ramps up

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Log in

Register for a new account

Billing Address

Payment Information We Accept Visa, Mastercard, American Express, and Discover